LUNG TRANSPLANTATION IN CYSTIC FIBROSIS PATIENT WITH CHRONIC AIRWAYS INFECTION OF BURKHOLDERIA CEPACIA (the first case in Russian Federation)

Cystic fibrosis (CF) is the third most common indication for lung transplantation. The recipients with CF have shown the best early and late survival rates after surgery. The special group of CF patients consists of those, whose airways were infected with Burkholderia cepacia (B. cepacia), since the recurrence of B. cepacia infection after transplantation are coupled with extremely high risk of death. Up to the present, the question whether the patients in such conditions should be included onto the lung transplant waiting list is still unanswered. We describe a case of lung transplantation in the patient with late postoperative complication in the form of severe pyoseptic infl ammatory process caused by the recurrence of B. cepacia infection. The success of the treatment of this patient was achieved thanks to combined multidisciplinary approach. This therapeutic approach could be considered as a standard treatment protocol in case of its validation by further clinical experience.

1. Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Goldfarb SB et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report-2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant. 2015; 34 (10): 1264– 1277.

2. Stephenson AL, Sykes J, Berthiaume Y, Singer LG, Aaron SD, Whitmore GA et al. Clinical and demographic factors associated with post-lung transplantation survival in individuals with cystic fibrosis. J Heart Lung Transplant. 2015; 34 (9); 1139–1145.

3. Weill D, Benden C, Corris PA, Dark JH, Davis RD, Keshavjee S et al. A consensus document for the selection of lung transplant candidates: 2014-an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2015; 34 (1): 1–15.

4. Olland A, Falcoz P-E, Kessler R, Massard G. Should cystic fibrosis patients infected with Burkholderia cepacia complex be listed for lung transplantation? Interact Cardiovasc Thorac Surg. 2011; 13 (6): 631–634.

5. O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009; 373 (9678): 1891–1904.

6. Красовский СА, Амелина ЕЛ, Черняк АВ, Никонова ВС, Воронкова АЮ, Каширская НЮ и др. Муковисцидоз взрослых: увеличение выживаемости больных в Москве и Московской области. Терапевтический архив. 2012; 84 (3): 54–58. Krasovsky SA, Amelina EL, Chernyak AV, Nikonova VS, Voronkova AYu, Kashirskaya NYu et al. Adult-onset mucoviscidosis: longer survival of patients in Moscow and Moscow region. Terapevticheskiy arkhiv. 2012; 84 (3): 54–58.

7. Ramos KJ, Quon BS, Psoter KJ, Lease ED, Mayer-hamblett N, Aitken ML et al. Predictors of non-referral of patients with cystic fibrosis for lung transplant evaluation in the United States. J Cyst Fibros. 2015; 1–8.

8. Mall J. Stuart MAE, editor. Cystic Fibrosis. European Respiratory Society. 2014: 332.

9. Семыкин СЮ, Постников СС, Поликарпова СВ, Нажимов ВП, Чернуха МЮ, Авакян ЛВ. Burcholderia сepacia – новая угроза для больных муковисцидозом. Детская больница. 2013; 2: 52–55. Semykin SYu, Postnikov SS, Polikarpova SV, Nazhimov VP, Chernukha MYu, Avakyan LV. Burcholderia cepacia – new threat for the patients with cystic fibrosis. Detskaya bol’nitsa. 2013; 2: 52–55.

10. Weidmann A, Webb AK, Dodd ME, Jones AM. Successful treatment of cepacia syndrome with combination nebulised and intravenous antibiotic therapy. J Cyst Fibros. 2008; 7 (5): 409–411.

11. Williams SG, Ashworth F, McAlweenie A, Poole S, Hodson ME, Westaby D. Percutaneous endoscopic gastrostomy feeding in patients with cystic. Gut. 1999; 44 (1): 87–90.

12. Dosanjh A. A review of nutritional problems and the cystic fibrosis lung transplant patient. Pediatr Transplant. 2002; 6 (6): 388–391.

13. De Soyza A, Meachery G, Hester KLM, Nicholson A, Parry G, Tocewicz K et al. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience. J Heart Lung Transplant. 2010; 29 (12): 1395–1404.

14. Hopkins PM, Kidd TJ, Coulter C, Feather IH, Derrington P, Bell SC. Death after lung transplantation in cystic fibrosis patients infected with Burkholderia cepacia. Am J Respir Crit Care Med. 2009; 179 (3): 257–258.

15. Boussaud V, Guillemain R, Grenet D, Coley N, Souilamas R, Bonnette P et al. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres. Thorax. 2008; 63 (8): 732– 737.

16. Гипербарическая медицина, практическое руководство (под редакцией Д. Матьё). М.: Бином, 2009: 720 (Перевод с англ.). Handbook on Hyperbaric Medicine (edit by D. Mathieu). M.: Binom, 2009: 720 (Translated from English).